Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9332)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2015 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Quirk M, Kim YH, Saab S, Lee EW. Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol 2015; 21(12): 3462-3471 [PMID: PMC4375567 DOI: 10.3748/wjg.v21.i12.3462] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i12/3462.htm |
| Number | Citing Articles |
| 1 |
Keisuke Arai, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Sachio Terai, Taku Matsumoto, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, Yonson Ku. Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis. Surgery Today 2017; 47(3): 385 doi: 10.1007/s00595-016-1384-7
|
| 2 |
Yuichi Goto, Yoshihiro Uchino, Shin Sasaki, Nobuhisa Shirahama, Yoriko Nomura, Jun Akiba, Hiroto Ishikawa, Yoshito Akagi, Hiroyuki Tanaka, Koji Okuda. Complete spontaneous necrosis of hepatocellular carcinoma accompanied by portal vein tumor thrombosis: A case report. International Journal of Surgery Case Reports 2018; 44: 220 doi: 10.1016/j.ijscr.2018.02.045
|
| 3 |
Chia-Ling Chiang, Huei-Lung Liang, Kuo-Chen Chang, Wei-Lun Tsai, Hsien-Chung Yu, Kung-Hung Lin, Ming-Feng Li. Advanced hepatocellular carcinoma with major portal vein invasion: Therapeutic outcomes of hepatic arterial infusion chemotherapy vs concurrent radiotherapy. Journal of the Chinese Medical Association 2024; 87(2): 171 doi: 10.1097/JCMA.0000000000001040
|
| 4 |
Jing-Yi Zhang, Da Xu, Zhen-Zhen Liu, Yuan Li, Li-Jun Wang, Bao-Cai Xing. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis. Chinese Medical Journal 2017; 130(4): 470 doi: 10.4103/0366-6999.199839
|
| 5 |
Brian K.P. Goh, Juinn Huar Kam, Ser‐Yee Lee, Chung‐Yip Chan, John C. Allen, Premaraj Jeyaraj, Peng‐Chung Cheow, Pierce K.H. Chow, London L.P.J. Ooi, Alexander Y.F. Chung. Significance of neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma. Journal of Surgical Oncology 2016; 113(6): 621 doi: 10.1002/jso.24197
|
| 6 |
Seyda Gunduz, Gia Saini, Nicole Segaran, Sailen Naidu, Indravadan Patel, Sadeer Alzubaidi, Rahmi Oklu. Radioembolization for Hepatocellular Carcinoma. Digestive Disease Interventions 2021; 5(03): 268 doi: 10.1055/s-0041-1732304
|
| 7 |
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Joji Tani, Teiji Kuzuya, Kazuhiro Kasai, Youhei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Satoshi Tanaka, Akihiro Deguchi, Shigeo Shimose, Tomotake Shirono, Miwa Sakai, Hiroyuki Suzuki, Etsuko Moriyama, Hironori Koga, Takuji Torimura, Takumi Kawaguchi. The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function. Cancers 2022; 14(19): 4873 doi: 10.3390/cancers14194873
|
| 8 |
Carla Rognoni, Oriana Ciani, Silvia Sommariva, Rosanna Tarricone. Real-World Data for the Evaluation of Transarterial Radioembolization versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis. Value in Health 2017; 20(3): 336 doi: 10.1016/j.jval.2016.09.2397
|
| 9 |
Diego A.S. Toesca, Aisling Barry, Gonzalo Sapisochin, Robert Beecroft, Laura Dawson, Dawn Owen, Samdeep Mouli, Robert Lewandowski, Riad Salem, Daniel T. Chang. Clinical Case Panel: Treatment Alternatives for Inoperable Hepatocellular Carcinoma. Seminars in Radiation Oncology 2018; 28(4): 295 doi: 10.1016/j.semradonc.2018.08.001
|
| 10 |
Hideki Iwamoto, Mika Nomiyama, Takashi Niizeki, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Manabu Satani, Syusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Ryoko Kuromatsu, Etsuyo Ogo, Toshi Abe, Masatoshi Tanaka, Hironori Koga, Takuji Torimura. Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy. Oncology 2019; 96(4): 192 doi: 10.1159/000495568
|
| 11 |
Yuki Nakajima, Atsushi Takahashi, Yukiko Kanno, Naohiko Gunji, Hiromichi Imaizumi, Manabu Hayashi, Ken Okai, Kazumichi Abe, Hiroshi Watanabe, Hiromasa Ohira. Paralytic Ileus due to Superior Mesenteric Venous Thrombosis after Transarterial Injection for Hepatocellular Carcinoma. Internal Medicine 2016; 55(1): 37 doi: 10.2169/internalmedicine.55.5907
|
| 12 |
Hongyuan Liang, Peng Cui, Qiyong Guo, Xiaonan Mao, Feng Wen, Wei Sun, Ming Shan, Zaiming Lu. Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization. Asia-Pacific Journal of Clinical Oncology 2017; 13(5) doi: 10.1111/ajco.12606
|
| 13 |
Jae Uk Chong, Gi Hong Choi, Dai Hoon Han, Kyung Sik Kim, Jinsil Seong, Kwang-Hyub Han, Jin Sub Choi. Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Annals of Surgical Oncology 2018; 25(11): 3308 doi: 10.1245/s10434-018-6653-9
|
| 14 |
Kaicai Liu, Chunze Zhou, Weifu Lv, Delei Cheng, Dong Lu, Zhengfeng Zhang, Jingkun Xiao, Xingming Zhang, Weiwei Fang. Factors to transcatheter arterial chemoembolization Liver Cancer stage C. Minimally Invasive Therapy & Allied Technologies 2020; 29(1): 49 doi: 10.1080/13645706.2019.1575241
|
| 15 |
Ming-Yang Chen, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Ngan-Ming Tsang, Kun-Ming Chan, Wei-Chen Lee. Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/6017406
|
| 16 |
Vishnu Prasad Pulappadi, Krithika Rangarajan, Sunil Kumar. Malignant Portal Vein Thrombosis in Adenosquamous Carcinoma of the Gall Bladder. Cureus 2024; doi: 10.7759/cureus.75790
|
| 17 |
Bao-Hong Yuan, Wei-Ping Yuan, Ru-Hong Li, Bang-De Xiang, Wen Feng Gong, Le-Qun Li, Jian-Hong Zhong. Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma. Tumor Biology 2016; 37(2): 2435 doi: 10.1007/s13277-015-4091-x
|
| 18 |
Giulia Malaguarnera, Vito Emanuele Catania, Saverio Latteri, Antonio Maria Borzì, Gaetano Bertino, Roberto Madeddu, Filippo Drago, Michele Malaguarnera. Folate levels in hepatocellular carcinoma patients with portal vein thrombosis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01525-3
|
| 19 |
Mai Nakamura, Kyoji Ito, Nobuyuki Takemura, Fuminori Mihara, Norihiro Kokudo. Hepatectomy for liver metastases from cervical cancer with portal vein tumor thrombosis: a case report. Clinical Journal of Gastroenterology 2022; 15(2): 441 doi: 10.1007/s12328-022-01603-x
|
| 20 |
Hikmet Akkiz, Brian I. Carr, Sedef Kuran, Ümit Karaoğullarından, Oguz Üsküdar, Salih Tokmak, Burcu Arslan, Figen Doran, Hüseyin Tugsan Balli, Abdulalh Ülkü, Tolga Atılgan Akçam, Halil İbrahim Bahçeci, Kamil Yalçın Polat, Necati Örmeci, Halis Şimşek, Abdullah Sonsuz, Ali Demir, Engin Altıntaş, Mehmet Demir, Kendal Yalçın, Nazım Ekinci, Ayşegül Harmancı Özakyol, Mehmet Yücesoy, Ahmet Uygun, Vito Guerra, Anıl Delik, Yaman Tokat, Sezai Yilmaz, Ahmet Bektaş, Murat Kılıç. Macroscopic Portal Vein Thrombosis in HCC Patients. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3120185
|
| 21 |
Hyo Jung Cho, Soon Sun Kim, So Young Kang, Min Jae Yang, Choong Kyun Noh, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Jin Hong Kim, Sung Won Cho, Jae Youn Cheong. A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status. Gut and Liver 2019; 13(5): 557 doi: 10.5009/gnl18444
|
| 22 |
Mohamed Houseni, Mahmoud Abdel Aziz Abdel Hady, Sameh Abokoura. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00276-6
|
| 23 |
Shivani Handa, Kamesh Gupta, Michelle Sterpi, Ahmad Khan, Abhinav Hoskote, Anup Kasi. Trends and In-Hospital Outcomes of Splanchnic Vein Thrombosis Associated with Gastrointestinal Malignancies: A Nationwide Analysis. Gastrointestinal Tumors 2021; 8(2): 71 doi: 10.1159/000513368
|
| 24 |
T. Yin, W. Li, P. Zhao, Y. Wang, J. Zheng. Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma. Clinical Radiology 2017; 72(2): 136 doi: 10.1016/j.crad.2016.10.022
|
| 25 |
Carmelo Pirri, Debora Emanuela Torre, Stefano Cisico, Laura Tini, Carla Stecco, Domenico Mangino, Raffaele De Caro. Transesophageal Echocardiography: Timely Resolution of an Urgent Right Atrial Mass/ Hepatocellular Carcinoma Thrombosis. Journal of Diagnostic Medical Sonography 2024; 40(5): 509 doi: 10.1177/87564793241228533
|
| 26 |
Richard S. Finn, Peter R. Galle, Michel Ducreux, Ann-Lii Cheng, Norelle Reilly, Alan Nicholas, Sairy Hernandez, Ning Ma, Philippe Merle, Riad Salem, Daneng Li, Valeriy Breder. Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150. Liver Cancer 2024; : 1 doi: 10.1159/000539897
|
| 27 |
Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Kaori Kuramitsu, Masahiro Kido, Hisoka Kinoshita, Taku Matsumoto, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Yonson Ku. Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report. Surgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0178-x
|
| 28 |
Ziwen Tao, Yuying Ruan, Zhi Peng, Kai Zhang, Yanjing Gao. Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.783574
|
| 29 |
Ming-Feng Li, Huei-Lung Liang, Chia-Ling Chiang, Wei-Lun Tsai, Wen-Chi Chen, Cheng-Chung Tsai, I-Shu Chen. New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion. Journal of Personalized Medicine 2022; 13(1): 88 doi: 10.3390/jpm13010088
|
| 30 |
Hossein Ghanaati, Mahyar Mohammadifard, Mahtab Mohammadifard. A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma. Journal of Family Medicine and Primary Care 2021; 10(10): 3553 doi: 10.4103/jfmpc.jfmpc_2347_20
|
| 31 |
Elise Verger, Pierre Drion, Geneviève Meffre, Claire Bernard, Luc Duwez, Nicolas Lepareur, Olivier Couturier, François Hindré, Roland Hustinx, Franck Lacoeuille, Hélder A. Santos. 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLOS ONE 2016; 11(10): e0164626 doi: 10.1371/journal.pone.0164626
|
| 32 |
Omri Cohen, Lucia Maria Caiano, Sarina Levy-Mendelovich. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations. Thrombosis Research 2024; 234: 75 doi: 10.1016/j.thromres.2023.12.014
|
| 33 |
A.H.K. Abdelmaksoud, A.O. Abdelaziz, M.M. Nabeel, I. Hamza, T.M. Elbaz, H.I. Shousha, R.S.M. Abdelhady, R. Lithy. Hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein thrombosis: a case–control study. Clinical Radiology 2021; 76(9): 709.e1 doi: 10.1016/j.crad.2021.03.022
|
| 34 |
Mohamed A. Hassan-Kadle, Marian Muse Osman, Esra Keles, Hasan Huseyin Eker, Kursad Nuri Baydili, Hussein Mahdi Ahmed, Abdirahman Abdikadir Osman, Dirk Uhlmann. Clinical Characteristics of Patients with Hepatocellular Carcinoma: A Single-Center 3-Year Experience from Somalia. International Journal of Hepatology 2022; 2022: 1 doi: 10.1155/2022/3370992
|
| 35 |
Junguo Liu, Jinjuan Zhang, Yijun Wang, Guiming Shu, Cheng Lou, Zhi Du. HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Medicine 2022; 101(51): e32390 doi: 10.1097/MD.0000000000032390
|
| 36 |
Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3545-5
|
| 37 |
Tao Li, Yuanzi Yu, Juan Liu, Xiangguo Tian, Meng Kong, Lei Wu, Shaocan Tang, Shengqing Gu, Jingfang Zhao, Yi Cui, Jinhua Hu. PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0229-6
|
| 38 |
Xuejiao Chen, Feng-Ru Tang, Frank Arfuso, Wen-Qi Cai, Zhaowu Ma, Jiyuan Yang, Gautam Sethi. The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma. Biomolecules 2019; 10(1): 66 doi: 10.3390/biom10010066
|
| 39 |
Gargi Kothari, Simon S. Lo, Matthew Foote, Arjun Sahgal, Irene Karam, Michael Lock, Gerrit J. Blom, Matthias Guckenberger, Ben J. Slotman, Shankar Siva. Alternate Fractionation in Radiotherapy. Medical Radiology 2017; : 323 doi: 10.1007/174_2017_38
|
| 40 |
Peter S. Potrebko, Ravi Shridhar, Matthew C. Biagioli, William F. Sensakovic, George Andl, Jan Poleszczuk, Timothy H. Fox. SPECT/CT image‐based dosimetry for Yttrium‐90 radionuclide therapy: Application to treatment response. Journal of Applied Clinical Medical Physics 2018; 19(5): 435 doi: 10.1002/acm2.12400
|
| 41 |
Hibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, Soichi Takeda, Takahiro Ozutsumi, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Daisuke Hokuto, Masayuki Sho, Hitoshi Yoshiji. Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report. Clinical Journal of Gastroenterology 2022; 15(5): 953 doi: 10.1007/s12328-022-01667-9
|
| 42 |
Kenji Yamaoka, Tomokazu Kawaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Takashi Nakahara, Atsushi Ohno, Eisuke Murakami, Daiki Miki, Masataka Tsuge, Keigo Chosa, Kazuo Awai, Junichi Hirokawa, Yasushi Nagata, Shiro Oka. Multidisciplinary treatment for patients with advanced hepatocellular carcinoma complicated by Vp4 portal vein tumor thrombosis: Combination of atezolizumab and bevacizumab after hepatic arterial infusion chemotherapy and radiotherapy: A case series. Medicine: Case Reports and Study Protocols 2024; 5(6): e00325 doi: 10.1097/MD9.0000000000000325
|
| 43 |
Eric A. Wang, Jeff P. Stein, Ross J. Bellavia, Scott R. Broadwell. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. International Journal of Clinical Practice 2017; 71(11): e12972 doi: 10.1111/ijcp.12972
|
| 44 |
Ashley L. Titan, Kelly Devereaux, John D. Louie, George A. Poultsides. Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma. Digestive Diseases and Sciences 2018; 63(6): 1419 doi: 10.1007/s10620-017-4797-2
|
| 45 |
XiuPing Zhang, Kang Wang, Meng Wang, Guang Yang, XiaoFei Ye, MengChao Wu, ShuQun Cheng. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Oncotarget 2017; 8(17): 29416 doi: 10.18632/oncotarget.15075
|
| 46 |
Kathie Wu, Catherine E Travaline, Leighton Elliot. Right Atrial Tumor Invasion: A Rare Presentation of Hepatocellular Carcinoma . Cureus 2022; doi: 10.7759/cureus.22901
|
| 47 |
Ramya Ramaswami, David J. Pinato, Keiichi Kubota, Mitsuru Ishizuka, Tadaaki Arizumi, Masatoshi Kudo, Jeong Won Jang, Young Woon Kim, Mario Pirisi, Elias Allara, Rohini Sharma. Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis. Medical Oncology 2016; 33(10) doi: 10.1007/s12032-016-0827-8
|
| 48 |
Imam Waked, Sarah Berhane, Hidenori Toyoda, Stephen L Chan, Nicholas Stern, Daniel Palmer, Toshifumi Tada, Winnie Yeo, Frankie Mo, Dominik Bettinger, Martha M Kirstein, Mercedes Iñarrairaegui, Asmaa Gomaa, Arndt Vogel, Tim Meyer, Bruno Sangro, Paul Lai, Takashi Kumada, Philip J Johnson. Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion. British Journal of Cancer 2017; 116(4): 448 doi: 10.1038/bjc.2016.423
|
| 49 |
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhiyun Yang. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07916-3
|
| 50 |
Lokesh Seth, Kevin L. Stephans. Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.91
|
| 51 |
Malkhaz Mizandari, Tamta Azrumelashvili, Natela Paksashvili, Nino Kikodze, Ia Pantsulaia, Nona Janikashvili, Tinatin Chikovani. Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal Ablation. Case Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/6843121
|
| 52 |
Shaheena Parveen, Syed Nisar Ahmad, Abdul Wahid Mir, Altaf Hussain Shah, Tariq Abdullah Mir, Zubaida Rasool, Mohamad Younis Bhat, Nazir Ahmad Dar, Gull Mohammad Bhat. Etiology, clinical profile, and treatment pattern of hepatocellular carcinoma at a tertiary care center in North India: A retrospective observational study. Cancer Research, Statistics, and Treatment 2023; 6(3): 400 doi: 10.4103/crst.crst_37_23
|
| 53 |
Stephen L Chan, Charing CN Chong, Anthony WH Chan, Darren MC Poon, Kenneth SH Chok. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World Journal of Gastroenterology 2016; 22(32): 7289-7300 doi: 10.3748/wjg.v22.i32.7289
|
| 54 |
Jin‐Cheng Wang, An‐Liang Xia, Yong Xu, Xiao‐Jie Lu. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Cellular Physiology 2019; 234(2): 1062 doi: 10.1002/jcp.27324
|
| 55 |
Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann. Contrast-enhanced ultrasound of malignant liver lesions. Abdominal Radiology 2018; 43(4): 819 doi: 10.1007/s00261-017-1360-8
|
| 56 |
Weixun Chen, Zhengnan Hu, Ganxun Li, Lei Zhang, Tao Li. The State of Systematic Therapies in Clinic for Hepatobiliary Cancers. Journal of Hepatocellular Carcinoma 2024; : 629 doi: 10.2147/JHC.S454666
|
| 57 |
Scott M. Thompson, Michael L. Wells, James C. Andrews, Eric C. Ehman, Christine O. Menias, Christopher L. Hallemeier, Lewis R. Roberts, Sudhakar K. Venkatesh. Venous invasion by hepatic tumors: imaging appearance and implications for management. Abdominal Radiology 2018; 43(8): 1947 doi: 10.1007/s00261-017-1298-x
|
| 58 |
Shuqun Cheng, Jiamei Yang, Feng Shen, Weiping Zhou, Yi Wang, Wenming Cong, Guang shun Yang, Hongyan Cheng, Heping Hu, Chunfang Gao, Jia Guo, Aijun Li, Yan Meng, Xiaoqing Jiang, Yefa Yang, Guojun Qian, Ming Luo, Bing Hu, Xiaobo Man, Baohua Zhang, Changqing Su, Feiguo Zhou, Nan Li, Jie Shi, Meng Wang, Yaxin Zheng, Weixing Guo, Juxian Sun, Hongyang Wang, Wan-yee Lau, Meng-chao Wu. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget 2016; 7(26): 40816 doi: 10.18632/oncotarget.8386
|
| 59 |
Nur Şener, Abdullah Yakupoğlu. Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement. Medicine 2023; 102(35): e34674 doi: 10.1097/MD.0000000000034674
|
| 60 |
Majd B Aboona, Wendi Zhou, Karn Wijarnpreecha. A Rare Type of Hepatocellular Carcinoma Presenting With Cardiac Thrombus. Cureus 2023; doi: 10.7759/cureus.39611
|
| 61 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2020; 12(6): 663-676 doi: 10.4251/wjgo.v12.i6.663
|
| 62 |
Zhiqiang Wu, Jian Gao, Wenquan Zhuang, Jianyong Yang, Wenbo Guo. Efficacy and safety of transcatheter arterial chemoembolization plus hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Journal of Cancer Research and Therapeutics 2022; 18(2): 345 doi: 10.4103/jcrt.jcrt_1078_21
|
| 63 |
Linda Galasso, Lucia Cerrito, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma. Cancers 2024; 16(19): 3247 doi: 10.3390/cancers16193247
|
| 64 |
Swetha Pentapati, Stephen Caucci, Shravya Balmuri, Vishal Devarkonda. Complete Remission of Advanced Hepatocellular Carcinoma in a Patient With Ulcerative Colitis Treated With Atezolizumab and Bevacizumab: A Case Report. Cureus 2023; doi: 10.7759/cureus.39538
|
| 65 |
Wenchang Yu, Weifu Liu, Kongzhi Zhang, Shiguang Chen, Xiaolong Wang. Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study. Cancer Immunology, Immunotherapy 2023; 72(11): 3609 doi: 10.1007/s00262-023-03511-6
|
| 66 |
Wenchao Hu, Guohong Cao, Shengli Ye, Jianfeng Xu, Jing Chen, Guoliang Shao. Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE. Medicine 2023; 102(24): e34054 doi: 10.1097/MD.0000000000034054
|
| 67 |
Xiao-Zhen Zhang, Jian-Jun Tu, Wei Chen, Tao Ma, Xue-Li Bai, Ting-Bo Liang. Gallbladder cancer with tumor thrombus in the portal vein. Medicine 2018; 97(16): e0271 doi: 10.1097/MD.0000000000010271
|
| 68 |
Jianchu Wang, Jinhong Luo, Xiaolan Yin, Wei Huang, Huangming Cao, Guilin Wang, Jincheng Wang, Jun Zhou. Jiedu Granule Combined with Transcatheter Arterial Chemoembolization and Gamma Knife Radiosurgery in Treating Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/4696843
|
| 69 |
Reza Jafarzadeh‐Esfehani, Seyed Mostafa Parizadeh, Amirsaeed Sabeti Aghabozorgi, Negar Yavari, Ariane Sadr‐Nabavi, Seyed Alireza Parizadeh, Maryam Ghandehari, Afsane Javanbakht, Afsaneh Rezaei‐Kalat, Seyed Mahdi Hassanian, Mohammad Vojdanparast, Gordon A. Ferns, Majid Khazaei, Amir Avan. Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events. Journal of Cellular Physiology 2020; 235(10): 6393 doi: 10.1002/jcp.29639
|
| 70 |
H. Abdella, M. K. Shaker, Iman Fawzy Montasser, M. Sobhi, H. Aly, A. Sayed, S. Saleh, A. El Dorry. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis. Indian Journal of Gastroenterology 2018; 37(2): 127 doi: 10.1007/s12664-018-0830-4
|
| 71 |
Luca Filippi, Giovan G. Di Costanzo, Antonio D’Agostini, Raffaella Tortora, Giuseppe Pelle, Roberto Cianni, Orazio Schillaci, Oreste Bagni. Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis. Nuclear Medicine Communications 2018; 39(9): 845 doi: 10.1097/MNM.0000000000000879
|
| 72 |
Jae Uk Chong, Jin Sub Choi. ASO Author Reflections: Identifying Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Annals of Surgical Oncology 2019; 26(S3): 551 doi: 10.1245/s10434-018-7018-0
|
| 73 |
Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Masatoshi Tanaka, Tomotake Shirono, Etsuko Moriyama, Yu Noda, Masahito Nakano, Hideya Suga, Ryoko Kuromatsu, Takuji Torimura, Hironori Koga, Takumi Kawaguchi. Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching. International Journal of Molecular Sciences 2023; 24(18): 13715 doi: 10.3390/ijms241813715
|
| 74 |
Wei Li, Yang Wang, Wenfeng Gao, Jiasheng Zheng. Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy. Medicine 2016; 95(47): e5422 doi: 10.1097/MD.0000000000005422
|
| 75 |
Daniel Meyers, Nancy A Nixon, Angela Franko, Danny Ng, Vincent C Tam. Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer. BMJ Case Reports 2017; : bcr2016218107 doi: 10.1136/bcr-2016-218107
|
| 76 |
Lin-Zhong Zhu, Song Xu, Hai-Long Qian. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. World Journal of Gastroenterology 2018; 24(23): 2501-2507 doi: 10.3748/wjg.v24.i23.2501
|
| 77 |
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
|
| 78 |
Courtney B. Sherman, Spencer Behr, Jennifer L. Dodge, John P. Roberts, Francis Y. Yao, Neil Mehta. Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A‐VENA Criteria. Liver Transplantation 2019; 25(2): 207 doi: 10.1002/lt.25345
|
| 79 |
Inês Botto, Juliana Serrazina, Carlos Rodrigues Freitas, Sofia Carvalhana, Gonçalo Nogueira-Costa, Helena Cortez-Pinto. Hepatocellular Carcinoma with Vascular and Cardiac Involvement in a Young Patient with Non-Cirrhotic Hepatitis B: A Case Report. GE - Portuguese Journal of Gastroenterology 2024; : 1 doi: 10.1159/000539093
|
| 80 |
Beau Toskich. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 213 doi: 10.1007/978-3-319-68082-8_12
|
| 81 |
Yunfeng Xu, Ze Zhang, Da Xu, Xin Yang, Lina Zhou, Ying Zhu. Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02108-2
|
| 82 |
Tao Sun, Lei Chen, Xuefeng Kan, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Haohao Lu, Chuansheng Zheng, San Lin You. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1255133
|
| 83 |
Matthew Wu, Michael Schuster, Micheal Tadros. Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00057
|
| 84 |
Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00581-8
|